Chairman & Founder, Dr. Prathap C. Reddy inaugurates Seevaram, Thuraipakkam outlet
Apollo Pharmacy, a part of Apollo Hospitals Enterprise, India’s largest integrated healthcare player today commissioned its 3000th retail unit at Seevaram, Thuraipakkam. Apollo Pharmacy was started in 1987 with the single-minded goal of ensuring consumers were protected from spurious drugs and had round-the-clock access to genuine life-saving and OTC drugs. It is today India’s largest retail pharmacy chain with a presence in 18 states across India covering over 400 cities and dispenses over 3.5 Lakh prescriptions per day.
Chairman & Founder Dr. Prathap C. Reddy’s message on this occasion, “I am very pleased that the movement against spurious drugs that we started in 1987 with a single store has today blossomed into a countrywide presence. Apollo Pharmacy has always upheld Apollo’s patient first philosophy and consumers can depend on us to always safeguard them when it matters most. We greatly value the trust that has been placed in us and as clinicians we appreciate the role pharmaceuticals play in the healthcare value chain.”
Speaking on the occasion, Ms. Shobana Kamineni, Joint Vice-Chairman Apollo Hospitals said, “Apollo Pharmacy is not just Asia’s first and largest branded pharmacy network, but it has pioneered value-added services like free home delivery, refill reminder programs and community health camps. She added that this milestone had been possible because of the trust customers have reposed in Apollo pharmacy and the commitment and hard work of its 19,000 dedicated employees who serve 3,50,000 customers per day in over 400 cities and towns in 18 states.
Apollo pharmacy has conceptualized new format stores with a focus on providing the latest therapies against NCD’s cognizant of the huge burden it places on public health and the nation’s economy. In the days to come Apollo pharmacy is looking to introduce several programs for chronic care and preventive care. This year, Apollo Pharmacy also introduced Holland & Barrett, UK’s leading wellness products part of its commitment towards strengthening Health & Wellness in India.
About Apollo Hospitals
It was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Over the years Apollo Hospitals has established itself as home to the largest cardiac practice in India with over 160,000 cardiac surgeries. Apollo Hospitals is also the world’s largest private cancer care provider and runs the world’s leading solid organ transplant program.
As Asia’s largest and most trusted healthcare group, its presence includes over 10,000 beds across 71 Hospitals, 3000 Pharmacies, over 90 Primary Care and Diagnostic Clinics, 110 plus Telemedicine Centres and 80 plus Apollo Munich Insurance branches spanning the length and breadth of the Country.
As an integrated healthcare service provider with Health Insurance services, Global Projects Consultancy capability, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research Apollo Hospitals has been at the forefront of new medical breakthroughs with the most recent investment being that of commissioning the first Proton Therapy Center across Asia, Africa and Australia in Chennai, India. Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of International standards within the reach of every individual.
In a rare honour, the Government of India issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 30 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.